6 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDsSkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritisEnrolling by invitationPhase 22026-09-28NCT07748728
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RecurrenceRecruitingPhase 32026-07-20NCT07208058
Evaluation of NWRD09 for HPV-16 Related Cervical HSILMorphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial LesionsNot yet recruitingPhase 22026-07-17NCT07712692
SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinomagastroesophageal junction adenocarcinomaNot yet recruitingPhase 22026-05-27NCT07609667
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract CancerBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract cancer, biliary tract disorder, neoplasmRecruitingPhase 1 / Phase 22026-03-03NCT06938321
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)Bacterial Infections and Mycoses, Infections, Pseudomonas infection, bacterial infectious disease, bronchial disorder, bronchiectasis, gram-negative bacterial infections, respiratory system disorderRecruitingNot stated2025-04-01NCT06760273